Blank Bio
PrivateLast Round
Seed
May 19, 2026
Total Funding Raised
$7.2M
Company Overview
Blank Bio is a biotechnology company that develops RNA foundation models to improve patient-level prediction, clinical trial design, and diagnostic accuracy in oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blank Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Blank Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 19, 2026 |
Blank Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Define Ventures | Seed |
| Ripple Ventures | Seed |
| Y Combinator | Seed |
| Leonis Capital | Seed |
| SignalFire | Seed |
| Nova Threshold | Seed |
Blank Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Blank Bio's valuation, stock price, and market status.